KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
100 Corporate Drive, Mahwah, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
REPRO MED SYSTEMS INC (to 6/3/2022)
Latest financial report
10-K - Q4 2024 - Mar 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 327 % -37%
Quick Ratio 53 % -54.4%
Debt-to-equity 51.2 % +67%
Return On Equity -33.5 % +35.5%
Return On Assets -22.2 % +44.3%
Operating Margin -19.2 % +46.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46M shares +0.54%
Common Stock, Shares, Outstanding 46M shares +0.63%
Entity Public Float 83.5M USD -24.9%
Common Stock, Value, Issued 494K USD +0.59%
Weighted Average Number of Shares Outstanding, Basic 45.8M shares +0.44%
Weighted Average Number of Shares Outstanding, Diluted 45.8M shares +0.44%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33.6M USD +18%
Research and Development Expense 5.26M USD -8.43%
Operating Income (Loss) -6.45M USD +37.2%
Nonoperating Income (Expense) 382K USD -22.9%
Income Tax Expense (Benefit) 3.97M USD
Net Income (Loss) Attributable to Parent -6.07M USD +55.9%
Earnings Per Share, Basic -0.13 USD/shares +56.7%
Earnings Per Share, Diluted -0.13 USD/shares +56.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.58M USD -16.6%
Accounts Receivable, after Allowance for Credit Loss, Current 5.72M USD +41.4%
Inventory, Net 2.8M USD -19.5%
Assets, Current 19.1M USD -5.55%
Deferred Income Tax Assets, Net 5.45M USD +54.7%
Property, Plant and Equipment, Net 4.29M USD +11.8%
Operating Lease, Right-of-Use Asset 2.97M USD -15.6%
Other Assets, Noncurrent 99K USD 0%
Assets 27.2M USD -4.37%
Accounts Payable, Current 1.65M USD +69.2%
Employee-related Liabilities, Current 811K USD +75.3%
Accrued Liabilities, Current 3.92M USD +129%
Liabilities, Current 7.2M USD +61.7%
Operating Lease, Liability, Noncurrent 3M USD -10.1%
Liabilities 10.4M USD +28.3%
Retained Earnings (Accumulated Deficit) -29.4M USD -26%
Stockholders' Equity Attributable to Parent 16.8M USD -17.4%
Liabilities and Equity 27.2M USD -4.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -347K USD +92.6%
Net Cash Provided by (Used in) Financing Activities -182K USD +23.8%
Net Cash Provided by (Used in) Investing Activities -133K USD +53.1%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 49.4M shares +0.59%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -662K USD +87.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.3K USD -0.24%
Deferred Tax Assets, Valuation Allowance 7.08M USD +18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 8.32M USD +20%
Operating Lease, Liability 3.4M USD -8.21%
Depreciation 228K USD +14%
Property, Plant and Equipment, Gross 7.76M USD +18.4%
Operating Lease, Liability, Current 400K USD +8.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 534K USD +4.28%
Lessee, Operating Lease, Liability, to be Paid, Year One 534K USD +4.28%
Deferred Income Tax Expense (Benefit) -5.47M USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 534K USD +4.28%
Lessee, Operating Lease, Liability, to be Paid, Year Four 521K USD +1.74%
Operating Lease, Payments 120K USD +5.76%
Depreciation, Depletion and Amortization 888K USD +2.08%
Deferred Tax Assets, Net of Valuation Allowance 1.24M USD +33.1%